Hold the syringe or pen at a 90-degree angle to your skin, inject steadily into fatty tissue (never into muscle), and avoid injecting into areas with existing bruises
The Lancet Investigational Trial Context: MASLD/Liver Fat (Nature Medicine, 2024) A Phase 2a investigational trial published in Nature Medicine found that the triple GIP/GLP-1/glucagon receptor agonist resulted in substantial reductions in liver fat content in participants with metabolic dysfunction-associated steatotic liver disease (MASLD)
To this end, we hypothesized that intermittent fasting from dawn to sunset practiced exclusively during the human activity hours for four weeks would be associated with an anticancer serum proteome response, upregulate anticancer proteins and regulatory proteins of DNA repair and insulin signaling, and downregulate pro-cancer proteins
Alcala, S
Fat tissue metabolism shifts in ways that researchers continue to study and understand
Liu Y, Hou Q, Wang R, Liu Y, Cheng Z (October 2023)